FilingPulse

TEVA insider transaction filings

TEVA PHARMACEUTICAL INDUSTRIES LTD — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-19. Screen TEVA transaction legs live →

FiledFormInsiderReported transactionsSource
2026-08-194Lippman Evan — EVP, Business DevelopmentSale (S): 18,600 @ $36.57EDGAR
2026-08-104Zaks Tal Zvi — DirectorSale (S): 17 @ $34.87EDGAR
2026-08-054Jover Placid — See "Remarks"Option exercise (M): 12,827 · Sale (S): 12,827 @ $34.88 · Option exercise (M): 12,827 (derivative) @ $0EDGAR
2026-08-054Hughes Eric A — See "Remarks"Option exercise (M): 52,744 · Sale (S): 25,578 @ $34.88 · Option exercise (M): 52,744 (derivative) @ $0EDGAR
2026-06-224Shields Matthew — EVP, Global OperationsSale (S): 9,989 @ $32.19EDGAR
2026-06-164Kalif Eliyahu Sharon — EVP, Chief Financial OfficerSale (S): 106,563 @ $34.10EDGAR
2026-06-084Lichtenstein Chen — DirectorOption exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0EDGAR
2026-06-084Satchi-Fainaro Ronit — DirectorOption exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0EDGAR
2026-06-084Elstein Amir — DirectorOption exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0EDGAR
2026-06-084Zaks Tal Zvi — DirectorOption exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0EDGAR
2026-06-084Nisen Perry — DirectorOption exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0EDGAR
2026-06-084Francis Richard D — President and CEOOption exercise (M): 13,043 · Sale (S): 6,153 @ $34.35 · Option exercise (M): 13,043 (derivative) @ $0EDGAR
2026-06-084Crane Rosemary A — DirectorOption exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0EDGAR
2026-06-084MIGNONE ROBERTO — DirectorOption exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0EDGAR
2026-06-084BARER SOL J — DirectorOption exercise (M): 21,739 · Option exercise (M): 21,739 (derivative) @ $0EDGAR
2026-06-084LIEBERMAN GERALD M — DirectorOption exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0EDGAR
2026-06-044Shields Matthew — EVP, Global OperationsOption exercise (M): 16,195 · Sale (S): 16,195 @ $32.87 · Option exercise (M): 16,195 (derivative) @ $0EDGAR
2026-06-014Lichtenstein Chen — DirectorGrant/award (A): 7,242 (derivative) @ $0EDGAR
2026-06-014Satchi-Fainaro Ronit — DirectorGrant/award (A): 7,242 (derivative) @ $0EDGAR
2026-06-014Elstein Amir — DirectorGrant/award (A): 7,242 (derivative) @ $0EDGAR
2026-06-014Zaks Tal Zvi — DirectorGrant/award (A): 7,242 (derivative) @ $0EDGAR
2026-06-014Nisen Perry — DirectorGrant/award (A): 7,242 (derivative) @ $0EDGAR
2026-06-014Crane Rosemary A — DirectorGrant/award (A): 7,242 (derivative) @ $0EDGAR
2026-06-014MIGNONE ROBERTO — DirectorGrant/award (A): 7,242 (derivative) @ $0EDGAR
2026-06-014BARER SOL J — DirectorGrant/award (A): 10,863 (derivative) @ $0EDGAR
2026-06-014LIEBERMAN GERALD M — DirectorGrant/award (A): 7,242 (derivative) @ $0EDGAR
2026-05-184Lippman Evan — EVP, Business DevelopmentOption exercise (M): 11,841 · Sale (S): 5,746 @ $35.58 · Option exercise (M): 74,008 · Sale (S): 35,912 @ $35.58 · Option exercise (M): 11,841 (derivative) @ $0 · Option exercise (M): 74,008 (derivative) @ $0EDGAR
2026-05-184Kalif Eliyahu Sharon — EVP, Chief Financial OfficerSale (S): 153,251 @ $35.61EDGAR
2026-05-074Weiss Amir — Chief Accounting OfficerSale (S): 10,679 @ $36EDGAR
2026-05-074Daniell Richard — EVP, Europe CommercialSale (S): 30,000 @ $35.40EDGAR
2026-05-044Fox Christine — EVP, U.S. CommercialSale (S): 21,258 @ $35.31EDGAR
2026-05-044Sabag Mark — See "Remarks"Sale (S): 144,180 @ $34.99EDGAR
2026-03-194Sabag Mark — See "Remarks"Sale (S): 62,102 @ $30.14EDGAR
2026-03-094Savage Brian — Interim Chief Legal OfficerOption exercise (M): 3,580 · Sale (S): 1,127 @ $31.67 · Option exercise (M): 3,580 (derivative) @ $0EDGAR
2026-03-094Jover Placid — See "Remarks"Option exercise (M): 14,150 · Sale (S): 14,150 @ $31.67 · Option exercise (M): 14,150 (derivative) @ $0EDGAR
2026-03-094Shields Matthew — EVP, Global OperationsOption exercise (M): 17,295 · Sale (S): 17,295 @ $31.67 · Option exercise (M): 17,295 (derivative) @ $0EDGAR
2026-03-094Fox Christine — EVP, U.S. CommercialOption exercise (M): 17,819 · Sale (S): 7,924 @ $31.67 · Option exercise (M): 17,819 (derivative) @ $0EDGAR
2026-03-094Hughes Eric A — See "Remarks"Option exercise (M): 19,654 · Sale (S): 9,533 @ $31.67 · Option exercise (M): 19,654 (derivative) @ $0EDGAR
2026-03-094Weiss Amir — Chief Accounting OfficerOption exercise (M): 3,537 · Option exercise (M): 3,537 (derivative) @ $0EDGAR
2026-03-094Kalif Eliyahu Sharon — EVP, Chief Financial OfficerOption exercise (M): 19,916 · Option exercise (M): 19,916 (derivative) @ $0EDGAR
2026-03-094Daniell Richard — EVP, Europe CommercialOption exercise (M): 17,295 · Sale (S): 17,295 @ $31.67 · Option exercise (M): 17,295 (derivative) @ $0EDGAR
2026-03-094Sabag Mark — See "Remarks"Option exercise (M): 15,723 · Option exercise (M): 15,723 (derivative) @ $0EDGAR
2026-03-094Francis Richard D — President and CEOOption exercise (M): 42,452 · Sale (S): 20,025 @ $31.67 · Option exercise (M): 42,452 (derivative) @ $0EDGAR
2026-03-064Savage Brian — Interim Chief Legal OfficerOption exercise (M): 4,744 · Sale (S): 1,489 @ $32.46 · Option exercise (M): 3,466 · Sale (S): 1,186 @ $32.46 · Option exercise (M): 4,744 (derivative) @ $0 · Option exercise (M): 3,766 (derivative) @ $0 · +1 moreEDGAR
2026-03-064Lippman Evan — EVP, Business DevelopmentGrant/award (A): 27,347 (derivative) @ $0EDGAR
2026-03-064Jover Placid — See "Remarks"Grant/award (A): 37,982 (derivative) @ $0EDGAR
2026-03-064Shields Matthew — EVP, Global OperationsGrant/award (A): 33,424 (derivative) @ $0EDGAR
2026-03-064Fox Christine — EVP, U.S. CommercialOption exercise (M): 20,461 · Sale (S): 9,098 @ $32.46 · Option exercise (M): 20,461 (derivative) @ $0 · Grant/award (A): 50,643 (derivative) @ $0EDGAR
2026-03-064Hughes Eric A — See "Remarks"Option exercise (M): 23,251 · Sale (S): 11,277 @ $32.46 · Option exercise (M): 23,251 (derivative) @ $0 · Grant/award (A): 50,643 (derivative) @ $0EDGAR
2026-03-064Weiss Amir — Chief Accounting OfficerOption exercise (M): 10,679 · Option exercise (M): 5,650 · Option exercise (M): 10,679 (derivative) @ $0 · Option exercise (M): 5,650 (derivative) @ $0 · Grant/award (A): 11,280 (derivative) @ $0EDGAR

Recent 8-K events — TEVA PHARMACEUTICAL INDUSTRIES LTD

FiledFormItems reportedSource
2026-07-298-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-05-288-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-04-298-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-01-288-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-01-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2025-12-118-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits		EDGAR
2025-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2025-07-308-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2025-06-058-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2025-05-288-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits		EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=TEVA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →